Skip to main content

Search form

Search

About the Department
Divisions
Faculty
- Distinguished Faculty
- Faculty Development
Patient Care
- Referrals
- In the Community
Research
Education and Training
MedicineNews

About the Department
Divisions
Faculty
- Distinguished Faculty
- Faculty Development
Patient Care
- Referrals
- In the Community
Research
Education and Training
MedicineNews

Home
Divisions
Hematologic Malignancies and Cellular Therapy
Research
Clinical Research

Hematologic Malignancies and Cellular Therapy

Clinical Research

Learn About Our Clinical Trials

BMT and Cellular Therapies
Leukemia and Multiple Myeloma
Lymphomas - Non-Hodgkins Lymphoma and Hodgkins Lymphoma

About
Faculty
Patient Care
Education and Training
Research
Division Events
Division News

Recent Articles

14 Medicine faculty selected for Leadership Development for Researchers (LEADER) Program

New Faculty: October 2020

Divisions select faculty recipients for 2020 Excellence in Education Awards

Call for applications: Duke UNC-Chapel Hill Immunotherapy Training Grant

13 Medicine faculty recognized by the School of Medicine

Recent publications by our faculty

Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.

Am J Hematol

Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.

Bone Marrow Transplant

Early Palliative Care Services and End-of-Life Care in Medicare Beneficiaries with Hematologic Malignancies: A Population-Based Retrospective Cohort Study.

Journal of Palliative Medicine

View all our publications

Quick Links

Diversity
Careers
Giving
About Duke and Durham

medschool.duke.edu
duke.edu
dukehealth.org

Copyright 2004-2019 Duke University and Duke University Health System, All rights reserved